U.S. Judge Ends Adani Bribery Case, but Calls DOJ Official's Conduct 'Highly Unusual'

Seeking AlphaAug 11 19:35

Trump's tariff plans send Indian generic drugmakers' shares lower

Gelonghui, July 22 | Indian pharmaceutical stocks declined after U.S. President Donald Trump announced a 100% tariff on generic drugs effective August 2028. The tariff rate will double one year later, reaching 200% in August 2029. India's Nifty Pharma Index fell by 1.9%. Sun Pharma dropped 1.9%, Cipla declined 2.6%, and Gland Pharma fell 3.8%. In the Indonesian market, Kalbe Farma dropped 2.7%.

Gelonghui FinanceJul 22 12:23

Global stock markets are tumbling, yet India stands apart—its lack of AI exposure has paradoxically become an advantage.

Over the past month, India's Nifty 50 Index rose by approximately 1% against the broader market trend, while the MSCI Emerging Markets Index declined by more than 9%. As global AI-related trades cooled, India’s relatively low exposure to AI became an advantage, attracting capital inflows. Additionally, falling oil prices, a stabilizing rupee, and improving earnings expectations provided further support. However, high valuations remain a key constraint, with over 30% of index constituents trading at price-to-earnings multiples above 50x, making it difficult to fundamentally reverse the prevailing trend of capital outflows.

wallstreetcnJul 17 22:40

India, the first country shorted by AI

Capital markets have cast their verdict with real money: global investors are systematically bearish on a nation's pillar industry.

BlockBeatsJul 8 12:40

Nifty 50 Index Is Stuck In Range, and It Could Get Worse Before It Gets Better

InvestingCubeJun 29 18:30

SocGen's 7 Key Market Calls: Capex Winners, Commodities, Value Laggards and More

Seeking AlphaJun 18 19:55